v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development expenses $ 2,016 $ 3,150 $ 4,148 $ 5,021
General and administrative expenses 1,384 1,646 3,455 3,273
Total operating expenses 3,400 4,796 7,603 8,294
Operating loss 3,400 4,796 7,603 8,294
Other (income) expense        
Change in fair value of derivative Liabilities (107) (1) 3,269
Other (income) expense, net 414 96 546 92
Finance income, net (29) (66)
Net Loss 3,814 4,756 8,148 11,589
Other comprehensive income:        
Foreign currency translation adjustment (8) (29) (11) (65)
Comprehensive loss for the period $ 3,806 $ 4,727 $ 8,137 $ 11,524
Basic net loss per common stock $ 0.76 $ 9.62 $ 2.44 $ 34.81
Diluted net loss per common stock $ 0.76 $ 9.62 $ 2.44 $ 34.81
Weighted average number of common stock used in computing basic loss per common stock 5,009,085 494,504 3,332,919 332,931
Weighted average number of common stock used in computing diluted loss per common stock 5,009,085 494,504 3,332,919 332,931